Amicus Therapeutics
FOLD
$10.28
Share price
1.08%
Change (1 day)
-10.92%
Change (1 year)
Categories
EPS for Amicus Therapeutics (FOLD)
EPS in 2023 (TTM): -$0.64
According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.64. In 2022 the company made an earnings per share (EPS) of -$0.82 an increase over its 2021 EPS that were of -$0.92.
EPS history for Amicus Therapeutics from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.64 | -21.95% |
| 2022 | -$0.82 | -10.87% |
| 2021 | -$0.92 | -14.02% |
| 2020 | -$1.07 | -29.14% |
| 2019 | -$1.51 | -18.82% |
| 2018 | -$1.86 | 1.64% |
| 2017 | -$1.83 | 22% |
| 2016 | -$1.50 | 26.05% |
| 2015 | -$1.19 | 27.96% |
| 2014 | -$0.93 | -19.13% |
| 2013 | -$1.15 | 5.5% |
| 2012 | -$1.09 | -15.5% |
| 2011 | -$1.29 | -35.18% |
| 2010 | -$1.99 | 610.71% |
| 2009 | -$0.28 | -83.91% |
| 2008 | -$1.74 | -86.15% |
| 2007 | -$12.57 | -85.97% |
| 2006 | -$89.59 | 82.72% |
| 2005 | -$49.03 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $2.86 | -546.21% | 🇩🇰 Denmark |
 Biogen BIIB | $18.46 | -2,984.38% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -646.99% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | -$0.68 | 6.25% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$2.82 | 340.63% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -221.67% | 🇺🇸 USA |